Neha Shah, M.D., M.P.H., is the Associate Director for Clinical Clinical and Laboratory Services in IHPT, working with the technical teams to improve laboratory and clinical services in all PEPFAR-funded programs. She serves as the agency POC for Uganda. In addition to these programmatic roles, Neha reviews PEPFAR-funded research activities.
Previously, Neha was a medical officer at the NIH, where she oversaw TB clinical research trials for ACTG studies. She also served as a field medical officer in the CDC’s Division of TB Elimination, first to the Chicago Department of Health and then the San Francisco TB Program and was Director, TB Free California within the California Department of Health’s TB Control Program for 10 years. She was also a CDC EIS officer in the Global AIDS Program, CDC’s original PEPFAR program.
Neha received her M.D. degree from New York Medical College, trained in Internal Medicine in the Boston University Program, and achieved her M.P.H. from the Johns Hopkins Bloomberg School of Public Health.
Neha has worked extensively in TB and HIV surveillance and has led TB and HIV outbreak investigations in many parts of the world. She also served in the Ebola response in 2014-15. Neha has overseen and/or contributed to the development of different TB treatment guidelines, particularly for MDR TB and recently to the introduction and evaluation of the 3-month (3-HP) TB chemoprophylaxis regimen in California. She has many peer-reviewed publications and has received many service awards, most recently as a 2019 CDC TB Elimination Champion.
Payam Nahid, Sundari R. Mase, Giovanni Battista Migliori, Giovanni Sotgiu, Graham H. Bothamley, Jan L. Brozek,Adithya Cattamanchi, J. Peter Cegielski, Lisa Chen, Charles L. Daley, Tracy L. Dalton, Raquel Duarte, Federica Fregonese, C. Robert Horsburgh, Jr., Faiz Ahmad Khan, Fayez Kheir, Zhiyi Lan, Alfred Lardizabal, Michael Lauzardo, Joan M. Mangan, Suzanne M. Marks, Lindsay McKenna, Dick Menzies, Carole D. Mitnick, Diana M. Nilsen, Farah Parvez, Charles A. Peloquin, Ann Raftery, H. Simon Schaaf, Neha S. Shah, Jeffrey R. Starke, John W. Wilson, Jonathan M. Wortham, Terence Chorba, and Barbara Seaworth; on behalf of the American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America. Treatment of Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. Am J Respir Crit Care Med Vol 200, Iss 10, pp e93–e142, Nov 15, 2019.
Sundari Mase, Terence Chorba, Samuel Parks, Ann Belanger, Felecia Dworkin, Barbara Seaworth, Jon Warkentin, Pennan Barry, Neha Shah. Bedaquiline for the Treatment of Multidrug-Resistant Tuberculosis in the United States. Clinical Infectious Diseases 2020;71(4):1010–1016.
N. S. Shah, J. Westenhouse, P. Lowenthal, G. Schecter, L. True, S. Mase, P. M. Barry, J. Flood. The California Multidrug-Resistant Tuberculosis Consult Service: a partnership of state and local programs. Public Health Action, Volume 8, Number 1, 2018, pp. 7-13.
Thai LH, Nhat LM, Shah N, Lyss S, Ackers M. Sensitivity, Completeness and Agreement of the Tuberculosis Electronic System in Ho Chi Minh City, Viet Nam. Public Health Action, Volume 7, Number 4, 21 December 2017, pp. 294-298(5)
NS Shah, A Flood-Bryzman, C Jeffries, J Scott. Towards a Generation Free of Tuberculosis: TB Disease and Infection in Individuals of College Age in the United States. J Am Coll Health. 2017 Aug 11.
Shah NS, Duong YT, Le LV, Tuan NA, Parekh BS, Ha HT, Pham QD, Cuc CT, Dobbs T, Tram TH, Lien TT, Wagar N, Yang C, Martin A, Wolfe M, Hien NT, Kim AA. Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates. AIDS Res Hum Retroviruses. 2017 Mar 13.
Neha S. Shah, SY Grace Lin, Pennan M. Barry, Yi-Ning Cheng, Gisela Schecter, and Ed Desmond. Clinical Impact on Tuberculosis Treatment Outcomes of Discordance Between Molecular and Growth-Based Assays for Rifampin Resistance, California 2003–2013. Open Forum Infect Dis 2016: 3 (3)
Scott JC, Shah N, Porco T, Flood J. Cost Resulting from Anti-Tuberculosis Drug Shortages in the United States: A Hypothetical Cohort Study. PLoS One. 2015 Aug 18;10(8)
Yen Duong; Reshma Kassanjee; Alex Welte; Meade Morgan; Anindya De; Trudy Dobbs; Erin Rottinghaus; Marcel E Curlin; Chonticha Kittinunvorakoon; Boonyos Raengsakulrach; Michael Martin; Kachit Choopanya; Suphak Vanichseni; Jiang Yan; Maofeng Qiu; Haiying Yu; Yan Hao; Neha Shah; Linh-Vi Le; Andrea A Kim; Nguyen Anh Tuan; William Ampofo; Bharat Parekh. Recalibration of the Limiting Antigen Avidity EIA to Determine Mean Duration of Recent Infection in Divergent HIV-1 Subtypes. PLoS One. 2015 Feb 24;10(2)
Neha S Shah, Evelyn Kim, Flor de Maria Hernández Ayala, Maria Elena Guardado Escobar, Ana Isabel Nieto, Andrea A Kim, Gabriela Paz-Bailey. Performance and comparison of self-reported STI symptoms among high-risk populations – MSM, sex workers, persons living with HIV/AIDS – in El Salvador. International Journal of STDs and AIDS. 2014 March